(3aR,4S,7R,7aS)-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione | CAS:14805-29-9

We serve (3aR,4S,7R,7aS)-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione CAS:14805-29-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(3aR,4S,7R,7aS)-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione

Chemical Name:(3aR,4S,7R,7aS)-Hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
CAS.NO:14805-29-9
Synonyms:(3aR,4S,7R,7aS)-rel-hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione
(1R,2S,6R,7S)-4-Azatricyclo[5.2.1.0]decane-3,5-dione
(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione
Molecular Formula:C9H11NO2
Molecular Weight:165.18900
 
Physical and Chemical Properties:
Density:1.4805
Melting point:148-158ºC
Boiling point:519.7ºC
Flash point:262.1ºC
 
Specification:
Appearance:White to off-white crystalline powder
Assay:≥98.0%
Loss on drying:≤0.5%
Endo isomerism:≤0.5%
Melting point:148-158ºC
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediates of Lurasidone
 
Note:The product under valid patents will not be offered to the countries covered by patents.



Contact us for information like (3aR,4S,7R,7aS)-rel-hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3aR,4S,7R,7aS) 4,7-Methano-1H-isoindole-1,3(2H)-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(1R,2S,6R,7S)-4-Azatricyclo[5.2.1.0]decane-3,5-dione Use and application,(3aR,4S,7R,7aS)-rel-hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione technical grade,usp/ep/jp grade.


Related News: Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”2,4-Dichloropyrido[2,3-d]pyrimidine manufacturer Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”4-chloro-N-methylpyridine-2-carboxamide supplier There’s a few factors that play into this.tyramine vendor There’s a few factors that play into this.The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills.